【24h】

Do Catheters Harm the Patient?

机译:导管伤害病人吗?

获取原文

摘要

There is an increasing use of central venous catheters (CVCs) as a first-line vascular access in incident hemodialy-sis (HD) patients. CVCs are associated with short-term complications related to the catheter insertion procedure and with long-term complications as a consequence of the intravascular interaction of catheter material with the venous endothelium. Removal of CVCs is also associated with specific risks, such as pulmonary or air embolism. Bacteremia and sepsis, however, are the most important risks associated with CVCs. In incident HD patients, the mortality risk from infection is highest during the first 6 months after dialysis initiation, and has steadily increased over the last decade. The relative risk for infection from CVCs in HD patients now clearly exceeds the risk for catheter-related infections in peritoneal dialysis (PD) patients. CVCs should therefore always be the last preference for vascular access in HD. The option for PD should always be evaluated before using CVCs as a permanent vascular access in end-stage renal disease patients.
机译:中央静脉导管(CVC)越来越多地利用入射血液透析(HD)患者的一线血管接入。 CVCs与导管插入程序相关的短期并发症有关,并且由于导管材料与静脉内皮的血管内相互作用而导致的长期并发症。除去CVC也与特定风险相关,例如肺或空气栓塞。然而,菌血症和败血症是与CVC相关的最重要的风险。在事件高清患者中,透析在透析发生后的前6个月内,感染的死亡风险最高,在过去十年中稳步增加。 HD患者中CVCs感染的相对风险现在明显超过了腹膜透析(PD)患者的导管相关感染风险。因此,CVC应该始终是HD中血管访问的最后一个偏好。在使用CVC作为末期肾病患者的永久血管接入之前,应始终评估PD的选项。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号